Valarian and 2F enter strategic partnership
Image courtesy 2F
While European defence spending undergoes its most significant expansion in decades, rising to €392 billion in 2025, a 79% increase from €218 billion in 2021, European fragmentation has historically undermined cost-effectiveness.
"Modern operations demand more than updated software, they demand controlled environments," said Enrique Oti, Chief Strategy Officer at Second Front. "Partnering with Valarian allows us to extend those guarantees into sovereign contexts in the UK, EU and beyond, enabling customers to deploy complex software stacks without external dependency."
The partnership unites Second Front's 2F Game Warden platform, proven in rapidly delivering secure, compliant software into US and allied classified environments, with Valarian's sovereign enclave architecture, designed to ensure sensitive systems operate seamlessly without bleed.
"European defence institutions aren't just increasing budgets, they're demanding infrastructure they can command end-to-end," said Max Buchan, CEO and Co-Founder of Valarian. "Second Front shares our view: sovereignty isn't a feature, it's architecture. As nations invest billions into capabilities they must control absolutely, the providers who eliminate dependency, not manage around it, will define the next generation of defence infrastructure."
Valarian's technology ensures sensitive systems do not 'phone home', creating independently controlled sovereign enclaves where mission-critical applications can run with full confidence in their integrity. This complements 2F's ability to rapidly bring commercial innovation into defence environments while maintaining robust assurance and compliance standards.
Together, 2F and Valarian are enabling a new generation of sovereign-by-design digital solutions with controlled deployment pathways, compartmentalised environments and audit-first infrastructure that aligns with European security, jurisdictional and accreditation requirements while maintaining the speed and flexibility of commercial innovation.
